Bristol-Myers Squibb Co. et al v. AstraZeneca Pharmaceuticals LP et al
| Bristol-Myers Squibb Co. and E. R. Squibb & Sons, L.L.C. |
| AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd. |
| 1:2022cv00346 |
| March 17, 2022 |
| US District Court for the District of Delaware |
| Matthew F Kennelly |
| Patent |
| 35 U.S.C. § 271 Patent Infringement |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 21, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 25
SCHEDULING ORDER: Joinder of Parties and Amended Pleadings due by 12/30/2022. Fact Discovery completed by 6/16/2023. Opening Expert Reports due by 7/28/2023. Rebuttal Expert Reports due by 8/25/2023. Expert Discovery due by 10/27/2023. Tutorial on the technology due by 3/17/2023. Dispositive Motions due by 11/10/2023. Claim Construction Opening Brief due by 2/3/2023. Claim Construction Answering Brief due by 2/17/2023. Claim Construction Reply Brief due by 3/3/2023. Joint Claim Construction Brief due by 1/27/2023. Motions in Limine due by 3/27/2024. Responses to Motions in Limine due by 4/3/2024. Proposed Pretrial Order due by 3/26/2024. A Pretrial Conference is set for 4/12/2024 at 10:00 AM before Judge Matthew F Kennelly. A Jury Trial is set for 4/22/2024 at 09:00 AM before Judge Matthew F Kennelly. (See Order for further deadlines). Signed by Judge Matthew F Kennelly on 5/10/2022. (twk)
|
|
Filing 24
PROPOSED ORDER Proposed Scheduling Order by Bristol-Myers Squibb Co., E. R. Squibb & Sons, L.L.C.. (Attachments: #1 Letter to The Honorable Matthew F. Kennelly)(Farnan, Brian)
|
|
Filing 23
NOTICE of Change of Address by Alexandra M. Joyce (Joyce, Alexandra)
|
|
Filing 22
NOTICE requesting Clerk to remove Angela C. Whitesell as co-counsel.. (Silver, Daniel)
|
|
Filing 21
ORAL ORDER: Telephonic status conference held. The parties are directed to confer and attempted to agree upon a pretrial and trial schedule. They are to file by 5/9/2022 a joint status report with an agreed proposal or separate proposals if they cannot agree. The motion for admission pro hac vice of David Berl; Thomas Fletcher; Kevin Hoagland-Hansen; and Matthew Heins is granted #16 . The Court disclosed on the record that Mr. Heins served as a law clerk for the Court approximately 6 years ago. The case is set for a telephonic status hearing on 5/24/2022 at 9:15 ET (8:15 CT). The following call-in number will be used: 888-684-8852; access code 746-1053. Ordered by Judge Matthew F Kennelly on 04/18/2022. (smg)
|
|
Filing 20
Joint STATUS REPORT by Bristol-Myers Squibb Co., E. R. Squibb & Sons, L.L.C.. (Farnan, Michael)
|
|
Filing 19
MOTION for Pro Hac Vice Appearance of Attorney David Berl, Thomas Fletcher, Kevin Hoagland-Hansen, and Matthew Heins - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Silver, Daniel)
|
|
Filing 18
STIPULATION AND ORDER, subject to the approval of the Court,that the deadline to submit a Joint Status Report is extended to and including April 13, 2022. Signed by Judge Matthew F Kennelly on 4/4/2022. (cna, )
|
|
Filing 17
STIPULATION TO EXTEND TIME the Deadline to Submit a Joint Status Report to April 13, 2022 - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Silver, Daniel)
|
|
Filing 16
ORDER SETTING TELECONFERENCE, the case is set for a telephonic status hearing on April 18, 2022 at 8:00 a.m. CDT (9:00 a.m. EDT), using call-in number 888-684-8852, access code 746- 1053. By April 8, 2022, the parties are to file a joint status report that includes the following information: (See Order for further details) Signed by Judge Matthew F Kennelly on 04/01/2022. (smg)
|
|
Case Reassigned to Judge Matthew F Kennelly of the United States District Court for the Northern District of Illinois. Please include the initials of the Judge (MFK) after the case number on all documents filed. (rjb)
|
|
Filing 15
NOTICE of Appearance by Matthew Alan Pearson on behalf of All Plaintiffs (Pearson, Matthew)
|
|
Pro Hac Vice Attorney Rachael Elsby, Melissa R. Gibson, Steven D. Maslowski, Karina J Moy, Anthony D Sierra, and Jason E. Weil for Bristol-Myers Squibb Co. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
|
|
Filing 14
SO ORDERED re #9 Stipulation and Order Regarding Service of Process on AstraZeneca UK Ltd. and to Extend Defendants' Response Time to Complaint (Set/Reset Answer Deadlines: AstraZeneca Pharmaceuticals LP answer due 5/23/2022; AstraZeneca UK Ltd. answer due 5/23/2022). Signed by Judge Maryellen Noreika on 3/24/2022. (dlw)
|
|
Filing 13
MOTION for Pro Hac Vice Appearance of Attorney Steven D. Maslowski, Melissa R. Gibson, Jason Weil, Karina J. Moy, Anthony D. Sierra, and Rachel J. Elsby - filed by Bristol-Myers Squibb Co., E. R. Squibb & Sons, L.L.C.. (Farnan, Brian)
|
|
Filing 12
NOTICE of Appearance by Alexandra M. Joyce on behalf of AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (Joyce, Alexandra)
|
|
Filing 11
NOTICE of Appearance by Angela Whitesell on behalf of AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (Whitesell, Angela)
|
|
Filing 10
NOTICE of Appearance by Daniel M. Silver on behalf of AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. (Silver, Daniel)
|
|
Filing 9
STIPULATION and [Proposed] Order Regarding Service of Process on AstraZeneca UK Ltd. and to Extend Defendants' Response Time to Complaint by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd.. (Joyce, Alexandra)
|
|
SO ORDERED re #13 MOTION for Pro Hac Vice Appearance of Attorney Steven D. Maslowski, Melissa R. Gibson, Jason Weil, Karina J. Moy, Anthony D. Sierra, and Rachel J. Elsby filed by E. R. Squibb & Sons, L.L.C., Bristol-Myers Squibb Co. ORDERED by Judge Maryellen Noreika on 3/24/2022. (dlw)
|
|
Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb)
|
|
Filing 8
STATEMENT re #7 Notice // Response to Notice of Related Cases by Bristol-Myers Squibb Co., E. R. Squibb & Sons, L.L.C. (Farnan, Michael) Modified on 3/24/2022 (dlw).
|
|
Filing 7
NOTICE of Related Cases by AstraZeneca Pharmaceuticals LP (Silver, Daniel)
|
|
Filing 6
SUMMONS Returned Executed by E. R. Squibb & Sons, L.L.C., Bristol-Myers Squibb Co.. AstraZeneca Pharmaceuticals LP served on 3/18/2022, answer due 4/8/2022. (Farnan, Michael)
|
|
Filing 5
Summons Issued as to AstraZeneca Pharmaceuticals LP on 3/18/2022. (mal)
|
|
Filing 4
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bristol-Myers Squibb Co. for E. R. Squibb & Sons, L.L.C. filed by Bristol-Myers Squibb Co., E. R. Squibb & Sons, L.L.C.. (mal)
|
|
Filing 3
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): see attached. (mal)
|
|
Filing 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal)
|
|
Filing 1
COMPLAINT filed with Jury Demand against AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3827324.) - filed by E. R. Squibb & Sons, L.L.C. and Bristol-Myers Squibb Co.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Civil Cover Sheet)(mal)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
